Decibel Therapeutics (DBTX) EBITDA (2021 - 2023)
Decibel Therapeutics (DBTX) EBITDA from Mar 31, 2021 to Jun 30, 2023. The TTM Decibel Therapeutics (DBTX) EBITDA is -$66M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Decibel Therapeutics (DBTX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +17.28% |
| All Time TTM | +23.20% |
Annual EBITDA change of Decibel Therapeutics (DBTX)
| Year | EBITDA | Change |
|---|---|---|
| 2023 | -$33M | -46.69% |
| 2022 | -$62M | +30.17% |
| 2021 | -$48M | N/A |